Expression of concern: Analysis of cataract-regulated genes using chemical DNA damage induction in a rat ex vivo model

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsConnexins and lens biology · Redox biology and oxidative stress · RNA regulation and disease
After this article [1] was published, concerns were raised about overlapping samples and microarray datasets between this article and articles [2–6] with the same ethical approval number. Specifically, the Control sample overlaps with articles [2–6].
In response to queries about these concerns the corresponding author stated that each article [1–6] used data from the same control microarrays, and that [1] is a follow-up to [5]. They stated that Robust Multichip Analysis correction was carried out for each raw dataset, and that differences arose in the processed data due to the different inhibitors in each article.
The corresponding author stated that [1] represents an analytical approach to comparing genes associated with cataract development induced using a method different from galactose as in articles [2–6] and also contributes to the elucidation of the full mechanism of cataract development alongside articles [2–6].
Based on input received from the PLOS One Editorial Board and a statistical reviewer, PLOS concluded that the microarray study design and data analyses were not performed to a high technical standard and call into question the reliability of the microarray results. Specifically:
The corresponding author provided additional information about the study design, specifically, that for RT-qPCR, n = 3 or more, of which 2 were obtained from two different animals (one eye = control and one eye = experimental), and the third was the RNA sample used for the microarray. They also stated that experimental groups were defined based on having the same opacity condition, rather than by time in culture.
Based on input from the PLOS One Editorial Board, PLOS concluded that the reliability of the microarray data is in question given the study design concerns, but the main conclusions in [1] are supported by the RT-qPCR results, which are not critically dependent on the microarray results and which validated the microarray findings pursued in [1] for follow-up studies.
The RT-qPCR data for [1] is provided here and the Data Availability statement is updated to: Microarray data are available in the GEO repository under the accession number GSE194317 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE194317). RT-qPCR data are available in the Supporting Information files.
The PLOS One Editors issue this Expression of Concern to inform readers of the above study design concerns and to provide the RT-qPCR data for [1].
Supporting information
S1 FileUnderlying RT-qPCR data for [1].(XLSX)
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Yamaoka R, Kanada F, Nagaya M, Takashima M, Takamura Y, Inatani M, et al. Analysis of cataract-regulated genes using chemical DNA damage induction in a rat ex vivo model. P Lo S One. 2022;17(12):e 0273456. doi: 10.1371/journal.pone.0273456 36477544 PMC 9728860 · doi ↗ · pubmed ↗
- 2Takashima M, Nagaya M, Takamura Y, Inatani M, Oki M. HIF-1 inhibition reverses opacity in a rat model of galactose-induced cataract. P Lo S One. 2024;19(2):e 0299145. doi: 10.1371/journal.pone.0299145 38416732 PMC 10901314 · doi ↗ · pubmed ↗
- 3Nagaya M, Kanada F, Takashima M, Takamura Y, Inatani M, Oki M. Atm inhibition decreases lens opacity in a rat model of galactose-induced cataract. P Lo S One. 2022;17(9):e 0274735. doi: 10.1371/journal.pone.0274735 36149903 PMC 9506662 · doi ↗ · pubmed ↗
- 4Kanada F, Takamura Y, Miyake S, Kamata K, Inami M, Inatani M, et al. Histone acetyltransferase and Polo-like kinase 3 inhibitors prevent rat galactose-induced cataract. Sci Rep. 2019;9(1):20085. doi: 10.1038/s 41598-019-56414-x 31882756 PMC 6934598 · doi ↗ · pubmed ↗
- 5Nagaya M, Yamaoka R, Kanada F, Sawa T, Takashima M, Takamura Y, et al. Histone acetyltransferase inhibition reverses opacity in rat galactose-induced cataract. P Lo S One. 2022;17(11):e 0273868. doi: 10.1371/journal.pone.0273868 36417410 PMC 9683626 · doi ↗ · pubmed ↗
- 6Masuda F, Inami M, Takamura Y, Inatani M, Oki M. Identification of genes contributing to attenuation of rat model of galactose-induced cataract by pyruvate. Genes Cells. 2024;29(10):876–88. doi: 10.1111/gtc.13150 39219252 PMC 11555625 · doi ↗ · pubmed ↗
